Urinary analysis of nephrolithiasis markers

被引:44
作者
Barbas, C
García, A
Saavedra, L
Muros, M
机构
[1] Univ San Pablo CEU, Fac CC Expt & Salud, Madrid 28668, Spain
[2] Hosp Virgen de Candelaria, Serv Anal Clin, Santa Cruz de Tenerife 38010, Spain
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2002年 / 781卷 / 1-2期
关键词
reviews; renal stones; oxalate; citrate;
D O I
10.1016/S1570-0232(02)00557-3
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Renal stone disease is an ancient and common affliction, common in industrialised nations. The causes and incidence of nephrolithiasis are presented. Afterwards, the promoters and inhibitors of renal stone formation analysis in urine are described including enzymatic methods, chromatography, capillary electrophoresis and other techniques. Aspects such as sample collection and storage are also included. The review article includes referenced tables that provide summaries of methodology for the analysis of nephrolithiasis related compounds. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:433 / 455
页数:23
相关论文
共 135 条
[1]  
ARNELLI A, 1993, CLIN CHEM, V39, P1558
[2]   THE ROLE OF CITRATE COMPLEXES IN PREVENTING UROLITHIASIS [J].
ASHBY, RA ;
SLEET, RJ .
CLINICA CHIMICA ACTA, 1992, 210 (03) :157-165
[3]   Metabolic urinary correlates of calcium oxalate dihydrate in renal stones [J].
Asplin, JR ;
Lingeman, J ;
Kahnoski, R ;
Mardis, H ;
Parks, JH ;
Coe, FL .
JOURNAL OF UROLOGY, 1998, 159 (03) :664-668
[4]   MOLECULAR CHARACTERISTICS OF URONIC-ACID-RICH PROTEIN, A STRONG INHIBITOR OF CALCIUM-OXALATE CRYSTALLIZATION INVITRO [J].
ATMANI, F ;
LACOUR, B ;
STRECKER, G ;
PARVY, P ;
DRUEKE, T ;
DAUDON, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 191 (03) :1158-1165
[5]  
BAIS R, 1985, CLIN CHEM, V31, P710
[6]   Solid-state 13C and 31P NMR analysis of urinary stones [J].
Bak, M ;
Thomsen, JK ;
Jakobsen, HJ ;
Petersen, SE ;
Petersen, TE ;
Nielsen, NC .
JOURNAL OF UROLOGY, 2000, 164 (03) :856-863
[7]  
Barbas C, 1999, PHYTOCHEM ANALYSIS, V10, P55, DOI 10.1002/(SICI)1099-1565(199903/04)10:2&lt
[8]  
55::AID-PCA437&gt
[9]  
3.0.CO
[10]  
2-I